|
Volumn 250, Issue 3, 2003, Pages 44-46
|
Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?
|
Author keywords
Double blind; Embryonic stem cells; Fluorodopa; Neurosurgery; Positron emission tomography (PET); Putamen
|
Indexed keywords
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
NEUROTROPHIC FACTOR;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
DRUG EFFICACY;
DRUG RESPONSE;
DYSKINESIA;
EMBRYONIC DOPAMINE CELL TRANSPLANTATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
NEUROSURGERY;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
BRAIN;
BRAIN TISSUE TRANSPLANTATION;
DISEASE PROGRESSION;
DOPAMINE;
DOUBLE-BLIND METHOD;
EMBRYO;
FETAL TISSUE TRANSPLANTATION;
HUMANS;
LEVODOPA;
MIDDLE AGED;
NEURONS;
PARKINSON DISEASE;
STEM CELL TRANSPLANTATION;
TOMOGRAPHY, EMISSION-COMPUTED;
TRANSPLANTS;
TREATMENT OUTCOME;
|
EID: 0142093660
PISSN: 09391517
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (50)
|
References (8)
|